Search research articles
Contact Us
Filters
Showing results (501-510 of 510) with videos related to
Page
of 51
Sort By:
You have reached the last page of results.
This site can display upto 510 results.
Journal of Hepatology
|
December 21, 2024
Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma
Sarah Cappuyns, Marta Piqué-Gili, Roger Esteban-Fabró, et al.
JAMA Oncology
|
March 6, 2020
Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients
Tobias Fehlmann, Mustafa Kahraman, Nicole Ludwig, et al.
Cell Reports. Medicine
|
April 1, 2025
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors
Ruth Plummer, Mikael H Sodergren, Rose Hodgson, et al.
International Journal of Public Health
|
February 24, 2022
COVID-19 in German Competitive Sports: Protocol for a Prospective Multicenter Cohort Study (CoSmo-S)
Andreas Michael Niess, Manuel Widmann, Roman Gaidai, et al.
Nature Communications
|
September 26, 2024
Decoding the diagnostic and therapeutic potential of microbiota using pan-body pan-disease microbiomics
Georges P Schmartz, Jacqueline Rehner, Madline P Gund, et al.
Nature Genetics
|
November 5, 2013
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
Joshua M Francis, Adam Kiezun, Alex H Ramos, et al.
Nature
|
January 29, 2025
Engineered heart muscle allografts for heart repair in primates and humans
Ahmad-Fawad Jebran, Tim Seidler, Malte Tiburcy, et al.
Journal of Hepatology
|
June 15, 2026
A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab Plus bevacizumab in hepatocellular caarcinoma
Pasquale Lombardi, Erik Ramon-Gil, Rabial Q Raja, et al.
Nature Communications
|
January 6, 2021
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy
Matt Lechner, Volker H Schartinger, Christopher D Steele, et al.
JHEP Reports : Innovation in Hepatology
|
March 1, 2021
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, et al.
Page
of 51
Search research articles
Search
Showing results (501-510 of 510) with videos related to
Sort By:
Page
of 51
You have reached the last page of results.
This site can display upto 510 results.
Journal of Hepatology
|
December 21, 2024
Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma
Sarah Cappuyns, Marta Piqué-Gili, Roger Esteban-Fabró, et al.
JAMA Oncology
|
March 6, 2020
Evaluating the Use of Circulating MicroRNA Profiles for Lung Cancer Detection in Symptomatic Patients
Tobias Fehlmann, Mustafa Kahraman, Nicole Ludwig, et al.
Cell Reports. Medicine
|
April 1, 2025
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors
Ruth Plummer, Mikael H Sodergren, Rose Hodgson, et al.
International Journal of Public Health
|
February 24, 2022
COVID-19 in German Competitive Sports: Protocol for a Prospective Multicenter Cohort Study (CoSmo-S)
Andreas Michael Niess, Manuel Widmann, Roman Gaidai, et al.
Nature Communications
|
September 26, 2024
Decoding the diagnostic and therapeutic potential of microbiota using pan-body pan-disease microbiomics
Georges P Schmartz, Jacqueline Rehner, Madline P Gund, et al.
Nature Genetics
|
November 5, 2013
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
Joshua M Francis, Adam Kiezun, Alex H Ramos, et al.
Nature
|
January 29, 2025
Engineered heart muscle allografts for heart repair in primates and humans
Ahmad-Fawad Jebran, Tim Seidler, Malte Tiburcy, et al.
Journal of Hepatology
|
June 15, 2026
A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab Plus bevacizumab in hepatocellular caarcinoma
Pasquale Lombardi, Erik Ramon-Gil, Rabial Q Raja, et al.
Nature Communications
|
January 6, 2021
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy
Matt Lechner, Volker H Schartinger, Christopher D Steele, et al.
JHEP Reports : Innovation in Hepatology
|
March 1, 2021
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, et al.
Page
of 51